Category: consumer health

  • How IoT Data Integration Helps Deliver Improved At-Home Healthcare in 2022

    Patricia (Pat) Black, Director of Technical Solutions at Cardinal Peak When it comes to your health and treatment, hospitals leverage a variety of sensors and instruments to collect the necessary information to monitor and diagnose your health status. With essential health data integrated into one platform, healthcare professionals are able to quickly and easily monitor […]

  • Pfizer will exit GSK consumer health JV after spinout

    GlaxoSmithKline is due to complete the split from its consumer health decision – now renamed Haleon – next month, with a listing for the new company on the London Stock Exchange set for 18 July. GSK said it has now filed a prospectus for the submission of Haleon’s ordinary shares to the stock market with the […]

  • J&J names CEO of its consumer health unit ahead of spinout

    Johnson & Johnson has appointed Thibaut Mongon as the chief executive of its consumer health division, which is scheduled to be spun off into a listed company by the end of 2023. J&J announced its intention to separate consumer health from its faster-growing prescription medicine and medical device businesses last November, creating a separate company […]

  • GSK names its consumer health spinoff Haleon

    GlaxoSmithKline’s consumer health business will be named Haleon following its planned spinoff and listing on the London Stock Exchange later this year, according to the drugmaker. The name of the unit – whose brands include Sensodyne toothpaste and Voltaren and Panadol painkillers and Centrum multivitamins – comes from the marriage of the word “hale”, meaning […]

  • Ipsen plans sale of consumer health business for €350m

    Ipsen has started exclusive negotiations that could see its global consumer health business sold to fellow French pharma company Mayoly Spindler later this year. If consummated, the deal would bring in around €350 million for Ipsen, leaving the company as a specialty pharma pure-play in cancer, rare diseases and neuroscience and ending its strategy of […]

  • J&J finally decides to dismantle its diversified business model

    After decades of a diversified healthcare business model, Johnson & Johnson has announced it plans to split off its consumer health division from its pharma and medical device operations. The move would create a new consumer health company within 18 to 24 months, according to J&J, which said it would unlock “significant value” whilst allowing […]

  • J&J is latest big pharma, device company to call it splits with consumer health

    Johnson & Johnson announced it plans to separate its consumer health products into a separate company, leaving the remaining business to focus on the more research-oriented pharmaceuticals and medical devices business segments. The announcement follows similar moves made by other large pharmaceutical and medical device companies.

  • Consumer health innovation – where passion and science meet

    Heather Barnes, external innovation lead EMEA at Johnson and Johnson Consumer Health, is a scientist who is truly passionate about consumer health. With her background in biochemistry and eye for identifying innovation trends, the future is bright at Johnson & Johnson Innovation. After making her way from early-stage drug development research to her current role, […]

  • GSK names McNamara as CEO of consumer health spinout

    GlaxoSmithKline has said that Brian McNamara – currently head of its three-year-old consumer health joint venture with Pfizer – will retain the top job at the business after it is hived off into a separate company next year. The appointment, which had been expected, was confirmed in a statement by GSK’s board today. McNamara has […]

  • GSK backs CEO Walmsley, rejecting Elliott’s call to change board

    GlaxoSmithKline’s board had responded to the broadside attack delivered by activist investor Elliott Management yesterday, saying it stands firmly behind the leadership of chief executive Emma Walmsley. The drugmaker rejected calls by Elliott to change its board and accelerate the complete divestment of its consumer health unit which is due to be split from the […]

  • Elliott fires broadside at GSK in wake of investor update

    GlaxoSmithKline chief executive Emma Walmsley was no doubt hoping that an upbeat assessment of the firm’s prospects at an investor meeting last week would deflect criticism of her leadership from activist investor Elliott Management – but finds herself in the firing line once again today. The US hedge fund, run by billionaire Paul Singer, has […]

  • Elliott fires broadside at GSK in wake of investor update

    GlaxoSmithKline chief executive Emma Walmsley was no doubt hoping that an upbeat assessment of the firm’s prospects at an investor meeting last week would deflect criticism of her leadership from activist investor Elliott Management – but finds herself in the firing line once again today. The US hedge fund, run by billionaire Paul Singer, has […]

  • GetWellNetwork Acquires Consumer Engagement Platform Docent Health

    What You Should Know: – GetWellNetwork is acquiring Docent Health, a digital health company. Docent provides a patient engagement platform used by healthcare organizations to coordinate personalized care at scale through AI-enabled communication technology. – The acquisition advances GetWellNetwork’s mission to empower patients and families to be more active participants in their care, and extends […]

  • CVS Health Launches Senior Medical Alert System, Symphony

    What You Should Know: – Today, CVS Health announced Symphony, a medical alert system designed to keep seniors safe and connected at home. – Symphony consists of a collection of in-home and wearable devices that offer a new at-home experience by connecting a suite of sensors that can monitor for falls, motion, and room temperature […]

  • How to Capitalize on Digital Health Momentum in 2021

    Adam Sabloff, Founder and CEO of VirtualHealth As we re-examine the healthcare system in the wake of the pandemic, we are continually identifying opportunities to rebuild parts of the system to new and improved specifications. One critical facet is digital health, where we continue to struggle with what should really be table stakes: the ability […]

  • Human API CEO Talks Data Privacy Concerns in Employee Wellness Programs

    Andrei Pop, Founder, and CEO of Human API, A recent BBC article discusses the rise in employee health tracking via wearable devices and highlights a number of concerns around data privacy. To try and prevent health tracking schemes from crossing ethical lines, and eroding trust between employee and employer, some industry figures believe that organizations […]

  • Human API Raises $20M+ to Scale User-Controlled Health Data Ecosystem

    What You Should Know: – Human API, the consumer-controlled health data platform announced it has closed a Series C round of $20M+ this week. – Human API’s consumer-controlled platform gives users a streamlined means of accessing and sharing their personal health records with physicians, trusted startups and enterprises, and insurers. – The platform harnesses a […]

  • Former KKR Vet Jim Momtazee Launches Healthcare Investment Firm, Patient Square Capital

    Jim Momtazee, Managing Partner at Patient Square Capital What You Should Know: – Former KKR veteran Jim Momtazee announced the launch of Patient Square Capital, a partnership being purpose-built to become the preeminent investment firm in healthcare.  – Patient Square will partner with best-in-class management teams whose products, services, and technologies improve health.  – Prior […]

  • Backed by Johnson & Johnson, Thirty Madison Raises $47M for Direct-to-Consumer Telehealth Brands

    What You Should Know: – Direct-to-consumer telehealth company Thirty Madison raises $47M in Series B round from Johnson & Johnson and Polaris Partners. – Thirty Madison’s three portfolio brands — Keeps, Cove, and Evens — enables patients to easily access specialist-level care combined with the convenience of telemedicine and treatment delivery.  Thirty Madison, a New York City-based digital health company reinventing the […]